Cargando…
Treatment outcome of oropharyngeal squamous cell carcinoma through propensity score analysis
According to an extensive database, the Objective is to compare surgical versus non-surgical treatment through Propensity Score (PS) for patients with Oropharyngeal Squamous Cell Carcinoma (OPSCC). METHODS: We retrospectively evaluated epidemiological data from 8075 patients with OPSCC diagnosed bet...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570559/ https://www.ncbi.nlm.nih.gov/pubmed/37813007 http://dx.doi.org/10.1016/j.bjorl.2023.101335 |
_version_ | 1785119795483508736 |
---|---|
author | Lau, Fabio Lisatchok, Matheus Tamanini, Jonas Belchior Gazmenga, Fabio Portela Texeira, Daniel Naves Araújo Couto, Eduardo Vieira Chone, Carlos Takahiro |
author_facet | Lau, Fabio Lisatchok, Matheus Tamanini, Jonas Belchior Gazmenga, Fabio Portela Texeira, Daniel Naves Araújo Couto, Eduardo Vieira Chone, Carlos Takahiro |
author_sort | Lau, Fabio |
collection | PubMed |
description | According to an extensive database, the Objective is to compare surgical versus non-surgical treatment through Propensity Score (PS) for patients with Oropharyngeal Squamous Cell Carcinoma (OPSCC). METHODS: We retrospectively evaluated epidemiological data from 8075 patients with OPSCC diagnosed between 2004 and 2014 and used PS matching to analyze possible prognostic factors for its outcomes with regression analyses. RESULTS: Cox multiple regression analysis to study survival after PS matching shows that type of treatment was associated with death with a hazard ratio of 1.753 (p < 0.05) of non-surgical treatment. However, it was not associated with recurrence (p > 0.05). In the surgical treatment group, overall survival was 79.9% at one year, 36.4% at five years, and 20.5% at ten years. Disease-free survival was 90.1%, 64.8%, and 56.0% at 1, 5, and 10-years, respectively. In the non-surgical treatment group, overall survival was 60.6% at one year, 21.8% at five years, and 12.7% at ten years. Disease-free survival was 90.8%, 67.2%, and 57.8% at 1, 5, and 10-years, respectively. CONCLUSION: Patients in the surgical treatment group had better outcomes related to survival. Recurrence is associated with the survival of OPSCC cancer. Recurrence-free survival is similar to both treatments. LEVEL OF EVIDENCE: 2C. |
format | Online Article Text |
id | pubmed-10570559 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-105705592023-10-14 Treatment outcome of oropharyngeal squamous cell carcinoma through propensity score analysis Lau, Fabio Lisatchok, Matheus Tamanini, Jonas Belchior Gazmenga, Fabio Portela Texeira, Daniel Naves Araújo Couto, Eduardo Vieira Chone, Carlos Takahiro Braz J Otorhinolaryngol Original Article According to an extensive database, the Objective is to compare surgical versus non-surgical treatment through Propensity Score (PS) for patients with Oropharyngeal Squamous Cell Carcinoma (OPSCC). METHODS: We retrospectively evaluated epidemiological data from 8075 patients with OPSCC diagnosed between 2004 and 2014 and used PS matching to analyze possible prognostic factors for its outcomes with regression analyses. RESULTS: Cox multiple regression analysis to study survival after PS matching shows that type of treatment was associated with death with a hazard ratio of 1.753 (p < 0.05) of non-surgical treatment. However, it was not associated with recurrence (p > 0.05). In the surgical treatment group, overall survival was 79.9% at one year, 36.4% at five years, and 20.5% at ten years. Disease-free survival was 90.1%, 64.8%, and 56.0% at 1, 5, and 10-years, respectively. In the non-surgical treatment group, overall survival was 60.6% at one year, 21.8% at five years, and 12.7% at ten years. Disease-free survival was 90.8%, 67.2%, and 57.8% at 1, 5, and 10-years, respectively. CONCLUSION: Patients in the surgical treatment group had better outcomes related to survival. Recurrence is associated with the survival of OPSCC cancer. Recurrence-free survival is similar to both treatments. LEVEL OF EVIDENCE: 2C. Elsevier 2023-09-23 /pmc/articles/PMC10570559/ /pubmed/37813007 http://dx.doi.org/10.1016/j.bjorl.2023.101335 Text en © 2023 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier España, S.L.U. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Original Article Lau, Fabio Lisatchok, Matheus Tamanini, Jonas Belchior Gazmenga, Fabio Portela Texeira, Daniel Naves Araújo Couto, Eduardo Vieira Chone, Carlos Takahiro Treatment outcome of oropharyngeal squamous cell carcinoma through propensity score analysis |
title | Treatment outcome of oropharyngeal squamous cell carcinoma through propensity score analysis |
title_full | Treatment outcome of oropharyngeal squamous cell carcinoma through propensity score analysis |
title_fullStr | Treatment outcome of oropharyngeal squamous cell carcinoma through propensity score analysis |
title_full_unstemmed | Treatment outcome of oropharyngeal squamous cell carcinoma through propensity score analysis |
title_short | Treatment outcome of oropharyngeal squamous cell carcinoma through propensity score analysis |
title_sort | treatment outcome of oropharyngeal squamous cell carcinoma through propensity score analysis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570559/ https://www.ncbi.nlm.nih.gov/pubmed/37813007 http://dx.doi.org/10.1016/j.bjorl.2023.101335 |
work_keys_str_mv | AT laufabio treatmentoutcomeoforopharyngealsquamouscellcarcinomathroughpropensityscoreanalysis AT lisatchokmatheus treatmentoutcomeoforopharyngealsquamouscellcarcinomathroughpropensityscoreanalysis AT tamaninijonasbelchior treatmentoutcomeoforopharyngealsquamouscellcarcinomathroughpropensityscoreanalysis AT gazmengafabioportela treatmentoutcomeoforopharyngealsquamouscellcarcinomathroughpropensityscoreanalysis AT texeiradanielnavesaraujo treatmentoutcomeoforopharyngealsquamouscellcarcinomathroughpropensityscoreanalysis AT coutoeduardovieira treatmentoutcomeoforopharyngealsquamouscellcarcinomathroughpropensityscoreanalysis AT chonecarlostakahiro treatmentoutcomeoforopharyngealsquamouscellcarcinomathroughpropensityscoreanalysis |